Berlin, Germany

Peter-Andreas Loschmann


Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 45(Granted Patents)


Location History:

  • Berlin, DE (1989 - 1996)
  • Hechingen, DE (2000)

Company Filing History:


Years Active: 1989-2000

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peter-Andreas Loschmann

Introduction

Peter-Andreas Loschmann, an esteemed inventor based in Berlin, Germany, has made significant strides in the pharmaceutical industry, particularly within the domain of treating complex diseases such as multiple sclerosis. With a total of five patents to his name, Loschmann's work showcases an innovative spirit and a commitment to improving patient outcomes.

Latest Patents

Among his latest inventions are two groundbreaking patents. The first patent focuses on a combined treatment for multiple sclerosis. This innovative pharmaceutical composition includes an effective mix of a PDE IV inhibitor along with anti-inflammatory and immunomodulatory drugs, all encapsulated in a pharmaceutically acceptable carrier. The second patent introduces N-(8.alpha.-ergolinyl)-amides, which highlights the potential of 8.alpha.-acylamino ergolines as effective dopamine agonists, presenting new avenues for neurological therapies.

Career Highlights

Peter-Andreas Loschmann currently works at Schering Aktiengesellschaft, a notable player in the pharmaceutical sector. His role has allowed him to contribute vital research and develop novel therapeutic solutions that address various health conditions. His expertise and innovative mindset have established him as a key figure in the industry, garnering respect and recognition.

Collaborations

Throughout his career, Loschmann has collaborated with other talented professionals, including Helmut Wachtel and Gerhard Sauer. This teamwork has amplified the impact of their research, combining different perspectives and expertise to drive innovation further in the fields they explore.

Conclusion

Peter-Andreas Loschmann's contributions to the pharmaceutical field are commendable, underscored by his patents that push the boundaries of medical research. His dedication to inventing and developing cutting-edge treatments not only benefits patients but also sets a benchmark for future innovations in the industry. As he continues his work with Schering Aktiengesellschaft, his future inventions will likely pave the way for more breakthroughs in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…